Sickle cell disease: open trials in Oman

• NCT06975865

  The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

  Trial Treatment · Phase 3 · Sanofi

  Muscat

  Registry updated 2026-10-15

• NCT06609226

  A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  Sultan Qaboos University Hospital, Muscat

  Registry updated 2026-09-18

• NCT06612268

  A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

  Trial Treatment · Phase 3 · Novo Nordisk A/S

  The Royal Hospital, Muscat · Sultan Qaboos University Hospital, Muscat

  Registry updated 2026-09-17

• NCT05953584

  A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

  Trial Treatment · Phase 2 · Forma Therapeutics, Inc.

  Sultan Qaboos University Hospital, Muscat

  Registry updated 2026-09-10

• NCT04657822

  Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Khoudh

  Registry updated 2026-06-08

All Sickle cell disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error